Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
OPERATING ACTIVITIES:
Consolidated net income	$ 1,448,000	$ 6,181,000
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:
Bad debt expense	15,000	29,000
Depreciation and amortization	1,690,000	770,000
Stock-based compensation expense	689,000	769,000
Amortization of debt issuance cost	6,000	0
Tax payments related to shares cancelled for vested restricted stock awards	(21,000)	(16,000)
Deferred income taxes	(1,427,000)	445,000
PPP Loan and interest forgiveness	0	(2,807,000)
Changes in operating assets and liabilities:
Trade accounts receivable	1,496,000	(7,882,000)
Inventories	(6,150,000)	(2,592,000)
Other current assets	(2,894,000)	(2,079,000)
Right of use assets	3,378,000	(35,000)
Other long-term assets	(225,000)	(1,000)
Accounts payable	1,065,000	2,030,000
Accrued expenses	3,063,000	2,479,000
Income taxes payable	759,000	(43,000)
Other long-term liabilities	0	(370,000)
Net cash provided by (used in) operating activities	2,892,000	(3,122,000)
INVESTING ACTIVITIES:
Capital expenditures	(2,675,000)	(227,000)
Net cash used in investing activities	(27,117,000)	(227,000)
FINANCING ACTIVITIES:
Proceeds from exercise of stock options	150,000	605,000
Debt issuance cost	(32,000)	0
Term Loan payments	(1,414,000)	0
Term Loan	17,000,000	0
Net cash provided by financing activities	15,704,000	605,000
Net decrease in cash and cash equivalents	(8,521,000)	(2,744,000)
Cash and cash equivalents, beginning of period	13,053,000	15,797,000
Cash and cash equivalents, end of period	4,532,000	13,053,000
Supplemental cash flow information – income taxes paid	(314,000)	949,000
Schrofftech [Member]
INVESTING ACTIVITIES:
Purchase of Microlab, net of cash acquired ($33)	$ (24,442,000)	$ 0